CTC Alternative Strategies’s Colgate-Palmolive CL Stock Holding History

CTC Alternative Strategies’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,504	Closed	-$225K	–	201
2024 Q1	$225K	Buy	+2,504	New	+$212K	0.14%	53
2023 Q3	–	Sell	-4,800	Closed	-$370K	–	100
2023 Q2	$370K	Buy	+4,800	New	+$372K	0.46%	57
2013 Q3	–	Sell	-8,200	Closed	-$470K	–	110
2013 Q2	$470K	Buy	+8,200	New	+$487K	0.13%	69

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

CTC Alternative Strategies's CL Position: Q2 2024 in Review

CTC Alternative Strategies sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 2,504 shares — an estimated $225K sold.

CTC Alternative Strategies first reported a position in CL in Q2 2013 and held it in 3 quarters. The position peaked at $470K in Q2 2013. 1,822 funds tracked by Wall St. Rank hold CL as of Q2 2024.

CTC Alternative Strategies reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
CTC Alternative Strategies sold 2,504 Colgate-Palmolive shares in Q2 2024, an estimated $225K.
CTC Alternative Strategies first reported a position in Colgate-Palmolive in Q2 2013 and held it in 3 quarters.
CTC Alternative Strategies's Colgate-Palmolive position peaked at $470K in Q2 2013.
1,822 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.